Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
Contacts
Capabilities
Suggested News & Insights
CFTC Division of Enforcement Issues New Cooperation PolicyMay 28, 2026DOJ Announces Accelerated Review of FCA Qui Tams Alleging Fraud Against State-Administered Benefits ProgramsMay 28, 2026DOJ Announces Accelerated Review of FCA Qui Tams Alleging Fraud Against State-Administered Benefits ProgramsMay 28, 2026Sidley and IIB Present Webinar on Trump Administration 5/19/26 EO “Restoring Integrity to America’s Financial System”Thursday, May 28, 2026OFAC Stresses Thorough U.S. Sanctions Diligence for Energy Transactions in $275 Million SettlementMay 27, 2026DOJ and Texas AG Announce First Settlement in National Investigation of Gender-Affirming Care for MinorsMay 26, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory